NASDAQ:REPL

Replimune Group Stock Forecast

etoro logo Buy REPL
*Your capital is at risk
$9.70
-0.760 (-7.27%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of REPL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add REPL to Watchlist?
Some Reasons Why To Add REPL:
  • +207.9% price growth over the last year
  • Bullish trend confirmed on both short and long timeframes
  • Consistently positive technical signals over the last month
PDF

Is Replimune Group Inc. stock still a buy after falling -7.27% on Friday?
(Updated on Jul 24, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 24, 2026

The Replimune Group Inc. stock price fell by -7.27% on the last day (Friday, 24th Jul 2026) from $10.46 to $9.70. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.74% from a day low at $9.65 to a day high of $10.30. The price has fallen in 7 of the last 10 days and is down by -11.74% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -525 thousand shares and in total, 3 million shares were bought and sold for approximately $31.68 million.

Given the current short-term trend, the stock is expected to rise 194.16% during the next 3 months and, with a 90% probability hold a price between $28.53 and $43.06 at the end of this 3-month period.

REPL Signals & Forecast

There are few to no technical positive signals at the moment. The Replimune Group Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.31 and $10.31. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -16.60%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Replimune Group Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $9.00 and $8.87. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Replimune Group Inc. finds support just below today's level at $9.00. If this is broken, then the next support from accumulated volume will be at $8.87 and $8.69.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.650 between high and low, or 6.74%. For the last week, the stock has had daily average volatility of 6.85%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (REPL) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Replimune Group Inc. to open at $9.88, and during the day (based on 14 day Average True Range), to move between $9.30 and $10.10, which gives a possible trading interval of +/-$0.80 (+/-8.62%) up or down from last closing price. If Replimune Group Inc. takes out the full calculated possible swing range there will be an estimated 8.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.87 (1.75%) than the support at $9.00 (7.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Replimune Group Inc. stock A Buy?

The Replimune Group Inc. stock holds several negative signals and despite the positive trend, we believe Replimune Group Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.425 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $9.88 ( 1.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

REPL Performance

Trading levels for REPL

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 10.53 8.59%
R2 10.29 6.03%
R1 10.13 4.45%
Price 9.70
S1 9.64 -0.670%
S2 9.48 -2.25%
S3 9.23 -4.81%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.63 19.90%
R2 9.98 2.89%
R1 9.87 1.75%
Price 9.70
S1 9.00 -7.22%
S2 8.87 -8.56%
S3 8.69 -10.41%

FAQ

What is the symbol for Replimune Group Inc. Stock and on which exchange is it traded?
The symbol for Replimune Group Inc. is REPL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Replimune Group Inc. Stock?
The Replimune Group Inc. stock holds several negative signals and despite the positive trend, we believe Replimune Group Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Replimune Group Inc. Stock?
Replimune Group Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Replimune Group Inc. Stock.

What's the current price of Replimune Group Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an Replimune Group Inc. (REPL) share was $9.70.

What is the 52-week high and low for Replimune Group Inc. Stock?
The 52-week high for Replimune Group Inc. Stock is $12.49 and the 52-week low is $1.50.

What is the market capitalization of Replimune Group Inc. Stock?
As of the Jul 24, 2026, the market capitalization of Replimune Group Inc. is 814.268M.

When is the next earnings date for Replimune Group Inc.?
The upcoming earnings date for Replimune Group Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT REPLIMUNE GROUP INC.
Replimune Group
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Pha...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE